DJIA 18,232.02 -53.72 -0.29%
NASDAQ 5,089.36 -1.43 -0.03%
S&P 500 2,126.06 -4.76 -0.22%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

59.38 -0.72 (-1.20%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $59.38 -1.20%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $60.07
Previous Close $60.10
Daily Range $59.34 - $60.07
52-Week Range $52.49 - $63.62
Market Cap $167.8B
P/E Ratio 15.69
Dividend (Yield) $1.80 (3.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 8,974,620
Average Daily Volume 10,844,179
Current FY EPS $3.43




Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

2 Stocks With Jaw-Dropping Growth Potential

These 2 companies are high-risk investments, but they nonetheless have the potential to become pivotal players in the rapidly expanding field of immuno-oncology. Here's why.

The 4 Stocks That Sank the DJIA on Friday

Expert Explains How To Play Merck In 2 Charts

IVV, JNJ, MRK, KO: ETF Outflow Alert

Health Care Sector Update for 05/22/2015: SRPT, AMGN, MRK

Achillion Pharmaceuticals: Should You Buy After The Sell-Off?

Bristol-Myers Squibb: Looking Ahead With Opdivo

Merck & ASCO: It Is All About Keytruda (Pembrolizumab)

Gilead, Merck And Achillion/J&J Square Off In An HCV 'Nuc'lear Showdown

Endo International Acquires Par Pharmaceuticals For $8 Billion

3 Big Pharmaceutical Stocks to Buy Right Now

See More MRK News...

MRK's Top Competitors

MRK $59.38 (-1.20%)
Current stock: MRK
JNJ $101.35 (-1.04%)
Current stock: JNJ
PFE $34.28 (-0.23%)
Current stock: PFE
RHHBY $36.83 (-0.94%)
Current stock: RHHBY